These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 11102800)

  • 1. Bacterial virulence as a target for antimicrobial chemotherapy.
    Alksne LE; Projan SJ
    Curr Opin Biotechnol; 2000 Dec; 11(6):625-36. PubMed ID: 11102800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virulence as a target for antimicrobial chemotherapy.
    Alksne LE
    Expert Opin Investig Drugs; 2002 Aug; 11(8):1149-59. PubMed ID: 12150708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-virulence Strategies to Target Bacterial Infections.
    Mühlen S; Dersch P
    Curr Top Microbiol Immunol; 2016; 398():147-183. PubMed ID: 26942418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel approaches to bacterial infection therapy by interfering with cell-to-cell signaling.
    Rasko DA; Sperandio V
    Curr Protoc Microbiol; 2009 Feb; Chapter 17():Unit17.3. PubMed ID: 19235150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small Molecules That Sabotage Bacterial Virulence.
    Johnson BK; Abramovitch RB
    Trends Pharmacol Sci; 2017 Apr; 38(4):339-362. PubMed ID: 28209403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel agents to inhibit microbial virulence and pathogenicity.
    Escaich S
    Expert Opin Ther Pat; 2010 Oct; 20(10):1401-18. PubMed ID: 20718591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-component systems regulate bacterial virulence in response to the host gastrointestinal environment and metabolic cues.
    Shaw C; Hess M; Weimer BC
    Virulence; 2022 Dec; 13(1):1666-1680. PubMed ID: 36128741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Important Complexities of the Antivirulence Target Paradigm: A Novel Ostensibly Resistance-Avoiding Approach for Treating Infections.
    Russo TA; Spellberg B; Johnson JR
    J Infect Dis; 2016 Mar; 213(6):901-3. PubMed ID: 26563238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Type III bacterial secretion system, a promising target for the development of a new generation of antibiotic drugs].
    Gintsburg AL; Zigangirova NA; Zorina VV
    Vestn Ross Akad Med Nauk; 2008; (10):34-9. PubMed ID: 19140396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of drug efflux pumps in bacterial multidrug resistance and virulence. Analysis to identify novel drug targets and counteract multidrug resistance and virulence].
    Nishino K
    Jpn J Antibiot; 2008 Apr; 61(2):105-13. PubMed ID: 18669419
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibitors of bacterial virulence identified in a surrogate host model.
    Benghezal M; Adam E; Lucas A; Burn C; Orchard MG; Deuschel C; Valentino E; Braillard S; Paccaud JP; Cosson P
    Cell Microbiol; 2007 May; 9(5):1336-42. PubMed ID: 17474906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Double-component bacterial regulation systems as a target for searching new antimicrobial agents].
    Tiganova IG; Il'ina TS; Romanova YM
    Mol Gen Mikrobiol Virusol; 2014; (3):3-12. PubMed ID: 25335406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New perspectives for a new century: implications of pathogen responses for the future of antimicrobial therapy.
    Melstrom KA; Smith JW; Gamelli RL; Shankar R
    J Burn Care Res; 2006; 27(3):251-64. PubMed ID: 16679890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disarming pathogens: benefits and challenges of antimicrobials that target bacterial virulence instead of growth and viability.
    Totsika M
    Future Med Chem; 2017 Mar; 9(3):267-269. PubMed ID: 28207349
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of metal ions in the virulence and viability of bacterial pathogens.
    Begg SL
    Biochem Soc Trans; 2019 Feb; 47(1):77-87. PubMed ID: 30626704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quorum sensing and quorum quenching: how to disrupt bacterial communication to inhibit virulence?].
    Mion S; Rémy B; Plener L; Chabrière É; Daudé D
    Med Sci (Paris); 2019 Jan; 35(1):31-38. PubMed ID: 30672458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial peptide resistance mechanisms of human bacterial pathogens.
    Nizet V
    Curr Issues Mol Biol; 2006 Jan; 8(1):11-26. PubMed ID: 16450883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. For the Greater (Bacterial) Good: Heterogeneous Expression of Energetically Costly Virulence Factors.
    Davis KM
    Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32041785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ionic Modulation of Bacterial Virulence and Its Role in Surgical Infection.
    Alverdy JC
    Surg Infect (Larchmt); 2018; 19(8):769-773. PubMed ID: 30359172
    [No Abstract]   [Full Text] [Related]  

  • 20. Interplay between iron homeostasis and virulence: Fur and RyhB as major regulators of bacterial pathogenicity.
    Porcheron G; Dozois CM
    Vet Microbiol; 2015 Aug; 179(1-2):2-14. PubMed ID: 25888312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.